Cargando…
The Co-infection of Mild COVID-19 and Rhinocerebral Mucormycosis in a Patient Without Diabetes or Prior Steroid Use
In a fast-evolving COVID-19 pandemic, co-infection with mucormycosis has been reported in some parts of the world. It is still unknown whether one of the either diseases makes the patient susceptible to developing the other. The co-occurrence of them significantly elevates the mortality risk and is...
Autores principales: | Sekar, Nishanth, Sundaresan, K T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189617/ https://www.ncbi.nlm.nih.gov/pubmed/35719782 http://dx.doi.org/10.7759/cureus.24986 |
Ejemplares similares
-
Rhinocerebral mucormycosis: a rare infection
por: Sellami, Moncef, et al.
Publicado: (2017) -
Rhinocerebral Mucormycosis and COVID-19 Pneumonia
por: Alekseyev, Kirill, et al.
Publicado: (2021) -
Rhinocerebral Mucormycosis Following COVID-19 Infection in Iran
por: Khorasani Esmaili, Parisa, et al.
Publicado: (2023) -
Case series of rhinocerebral mucormycosis occurring in diabetic patients
por: Mohammadi, Rasoul, et al.
Publicado: (2015) -
Rhinocerebral mucormycosis to the rise? The impact of the worldwide diabetes epidemic()()
por: Martínez-Herrera, Erick, et al.
Publicado: (2021)